Crown Laboratories Acquires Revance Therapeutics, Expanding Aesthetic Portfolio
The deal expands Crown’s presence in the aesthetics market, bringing Daxxify and the RHA Collection into its portfolio.
The deal expands Crown’s presence in the aesthetics market, bringing Daxxify and the RHA Collection into its portfolio.
An analysis of national search trends and surgeon workforce data highlights rising patient interest in aesthetic procedures across Southern, Midwestern, and rural regions where access to board-certified plastic surgeons remains limited.